We are live on ! Find out more
FLNA

Filana Therapeutics
FLNA

49 hedge funds and large institutions have $37.2M invested in Filana Therapeutics in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 11 increasing their positions, 19 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $15K | Put options by funds: $5K

5% more capital invested

Capital invested by funds: $35.6M → $37.2M (+$1.61M)

26% less funds holding

Funds holding: 66 → 49 (-17)

42% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 19

85% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 20

Holders
49
Holders Change
-17
Holders Change %
-25.76%
% of All Funds
1.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
11
Reduced
19
Closed
20
Calls
$15K
Puts
$5K
Net Calls
+$10K
Net Calls Change
+$12K

Top Buyers

Rank Fund Capital Flow
1
BI
BVF Inc
California
+$1.67M
2
Renaissance Technologies
Renaissance Technologies
New York
+$138K
3
BCM
Bridgeway Capital Management
Texas
+$129K
4
Connor, Clark & Lunn Investment Management (CC&L)
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
+$66.5K
5
Vanguard Group
Vanguard Group
Pennsylvania
+$64.2K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$546K
2
Goldman Sachs
Goldman Sachs
New York
-$440K
3
Susquehanna International Group
Susquehanna International Group
Pennsylvania
-$320K
4
MERSOM
Municipal Employees' Retirement System of Michigan
Michigan
-$141K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$117K
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
51
Moore Capital Management
New York
– -$87K -7,143 Closed
TCIM
52
TIAA CREF Investment Management
New York
– -$85K -7,009 Closed
CS
53
Credit Suisse
Switzerland
– -$84K -6,925 Closed
LP
54
LMR Partners
United Kingdom
– -$74K -6,191 Closed
Squarepoint
55
Squarepoint
New York
– -$71K -5,886 Closed
AGM
56
Alpine Global Management
New York
– -$53K -4,401 Closed
SFM
57
Soros Fund Management
New York
– -$38K -3,100 Closed
Jane Street
58
Jane Street
New York
– -$36K -2,982 Closed
Two Sigma Investments
59
Two Sigma Investments
New York
– -$35K -2,920 Closed
Verition Fund Management
60
Verition Fund Management
Connecticut
– -$34K -2,847 Closed
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
– -$27K -2,243 Closed
Two Sigma Advisers
62
Two Sigma Advisers
New York
– -$23K -1,906 Closed
Balyasny Asset Management
63
Balyasny Asset Management
Illinois
– -$19K -1,536 Closed
Deutsche Bank
64
Deutsche Bank
Germany
– -$6K -542 Closed
TRCT
65
Tower Research Capital (TRC)
New York
– -$2K -202 Closed
Simplex Trading
66
Simplex Trading
Illinois
– -$1K -132 Closed
1 2
3

FLNA Hedge Fund Activity: Q3 2015 in Review

49 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Filana Therapeutics (FLNA) for Q3 2015, worth a combined $37.2M — up 4.5% from $35.6M a quarter earlier.

Sellers outnumbered buyers: 20 funds closed out of FLNA and 3 opened new positions — a net loss of 17 holders — while 19 trimmed existing stakes and 11 added.

The largest buyer was BVF Inc, opening a new position worth an estimated $1.67M. The largest seller was Northern Trust, cutting an estimated $546K.

  • 49 institutional investors held Filana Therapeutics (FLNA) as of Q3 2015, down from 66 in Q2 2015.
  • Funds reported $37.2M of Filana Therapeutics stock for Q3 2015, up 4.5% quarter-over-quarter.
  • 3 funds opened new Filana Therapeutics positions in Q3 2015 and 20 closed out, a net change of -17 holders.
  • The largest Filana Therapeutics buyer in Q3 2015 was BVF Inc, an estimated $1.67M added.
  • The largest Filana Therapeutics seller in Q3 2015 was Northern Trust, an estimated $546K sold.

Based on aggregated 13F filings for Q3 2015.